clinicalomicsprowebdirectory
Facebook
Linkedin
Twitter
News
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Search
Facebook
Linkedin
Twitter
Update Preferences
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Inside Precision Medicine
News
News & Features
Can New Biomarker Data Improve Cardiovascular Risk Assessment?
News & Features
Blood Pressure Drugs More than Double Life-Threatening Bone Fracture Risk of…
News & Features
Dual-Action Drug Spurs Twice the Weight Loss in Mice as GLP-1…
News & Features
Robot-Inspired Therapy Could Help Children with Autism
News & Features
Immunotherapy before and after Surgery Improves Survival in Lung Cancer Patients
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Inside Precision Medicine
Enlaza Nets $100M to Advance Covalent Biologics Platform
Small molecules
News & Features
Enlaza Nets $100M to Advance Covalent Biologics Platform
Malorye Branca
-
May 1, 2024
0
News & Features
AI That Predicts Targeted Cancer Drug Response with Single-Cell Precision
Malorye Branca
-
April 18, 2024
0
News & Features
Obsidian Raises $160M+ to Advance Novel Solid Tumor Immunotherapy
Malorye Branca
-
April 5, 2024
0
News & Features
Novo Nordisk Inks $1.46B Deal with Neomorph for Molecular Glue Degraders
Malorye Branca
-
February 27, 2024
0
News & Features
DeepMind’s Isomorphic Inks $3B Worth of Deals with Lilly and Novartis in One Day
Malorye Branca
-
January 8, 2024
0
News & Features
Oral Cyclic Peptides Synthesized in Advance for Drug Discovery
Malorye Branca
-
December 28, 2023
0
News & Features
Depixus and Daiichi Sankyo Collaborate to Produce RNA-Targeted Drugs
Helen Albert
-
December 12, 2023
0
News & Features
Ajinomoto Acquires Gene Therapy Manufacturer for More than $550M
Malorye Branca
-
November 15, 2023
0
News & Features
In Potential $2B Deal, AstraZeneca Licenses Oral GLP-1 Agonist for Weight Loss
Malorye Branca
-
November 9, 2023
0
News & Features
Five Key Precision Medicine Players With Products in the Market
Jonathan Smith
-
October 18, 2023
0
1
2
Page 1 of 2
Related Content
Patients Aged 80 to 90 Respond to Standard-of-Care AML Treatment
Takeda Signs Deal Worth $2.2 Billion with AC Immune for Alzheimer’s Vaccine
Zenas Nets $200M to Advance mAb for Autoimmune Diseases
Cancer-Like Features in Atherosclerosis Provide New Opportunity for Treatment
Inside Precision Medicine